Whalesbook
Stock Surges on Trial Success
Tejas Networks' stock price jumped significantly, rising about 14-20% on Thursday and extending a four-day rally. Shares hit an intraday high of ₹531.85 with 18.10 million shares traded, indicating strong investor interest. The surge followed reports that Tejas Networks' equipment successfully completed laboratory and field trials for Direct-to-Mobile (D2M) broadcasting, backed by multiple government ministries. Validation from officials representing the Ministry of Information and Broadcasting, Ministry of Electronics and Information Technology, Department of Telecommunications, and Prasar Bharati is a key step that could lead to wider commercial use of the technology.
D2M Technology and Market Potential
The D2M technology, tested on the ATSC 3.0 standard using Tejas Networks' MarkOne D2M handset in the 470-582MHz spectrum band, represents a major advancement. It allows multimedia content to be broadcast directly to mobile devices without using internet data, which could help ease congestion on current networks and improve content access. This is significant for India, a fast-growing digital economy. The trials confirmed no interference with existing 2G, 3G, 4G, and 5G services, addressing concerns previously voiced by major telecom operators like Reliance Jio, Bharti Airtel, and Vodafone Idea about trial transparency. While the broader telecom sector saw a slight dip recently, Tejas Networks' strong performance helped the BSE Telecom index become the day's top performer. Tejas Networks competes globally with companies like Nokia and Ericsson, and domestically with HFCL and STL. Its strength in domestic optical access is a good position, though international expansion faces challenges from established players. Analysts are positive on the D2M initiative, seeing it as a way to transform content distribution by enabling direct TV broadcasts on mobile phones. The consensus analyst recommendation is 'Strong Buy', with price targets indicating potential upside.
Financial Challenges and Risks
However, significant underlying risks and past operational issues temper the positive sentiment from the D2M trials. Tejas Networks' financial performance shows a negative P/E ratio (-8.11 to -9.05), indicating current unprofitability. Recent reports reveal concerning trends: Q3 FY2026 posted a net loss of ₹196.55 crores and an 88% year-on-year revenue drop to ₹306.79 crores, following a Q4 FY2025 net loss of ₹72 crore and a substantial revenue decline. Trade receivables have climbed to over ₹4,800 crores, straining the cash cycle and leading to a rise in short-term borrowing to ₹3,269 crores. The order book has also contracted sharply from ₹8,221 crores to ₹1,019 crores by the end of FY2025, largely due to the completion of a major BSNL order. Reliance on large, single orders, especially from government bodies like BSNL, often means lower margins and payment uncertainties, as indicated by high receivables. Management changes, including the retirement of CEO Sanjay Nayak, also introduce elements of operational evolution. Competition from global players in profitable segments and the expense of expanding manufacturing capacity remain ongoing challenges. Past volatility, including a revenue crash following the 2G scam and a stock price drop of 64.37% from its 52-week high (₹1,175.00 as of January 2026), underscores the execution risks in Tejas Networks' business model.
Outlook and Analyst Views
The successful D2M trial clearance is a key milestone that could open new revenue avenues for Tejas Networks. The technology's ability to reduce data network congestion and improve content delivery in India positions the company well in a fast-growing telecom and digital broadcasting market. Analysts generally remain optimistic, with a consensus 'Strong Buy' recommendation and price targets suggesting significant potential upside, driven by 5G expansion and possible international growth. Tejas Networks' continued product development, existing strength in optical and wireless solutions, and strategic partnerships will be vital for diversifying its order book and seizing the D2M opportunity. However, the speed of commercialization, navigating regulations, and securing consistent orders are critical for turning this trial success into sustained financial results.